Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 16Recruiting 13Unknown 8Terminated 4Withdrawn 3Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 3Neoplasms 3Leukemia, Myeloid, Acute 3Breast Neoplasms 3Pancreatic Neoplasms 2Neoplastic Cells, Circulating 2Lung Neoplasms 2Gastrointestinal Neoplasms 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma, Myeloid 1Rectal Neoplasms 1Pruritus 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Pancreatic Adenocarcinoma 1Overweight 1Oropharyngeal Neoplasms 1Opioid-Related Disorders 1Obesity 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Multiple Myeloma 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Follicular 1Liver Neoplasms 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Leukemia 1

Interventions

Docetaxel 11Prednisone 10Leuprolide 10Magnetic Resonance Spectroscopy 9bicalutamide 8Radiotherapy 7Abiraterone Acetate 7Biopsy 6gallium 68 PSMA-11 5acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 5Surveys and Questionnaires 5Metformin 5Goserelin 5radium Ra 223 dichloride 4enzalutamide 4apalutamide 4Specimen Handling 4Injections 4Androgen Antagonists 4pembrolizumab 3orteronel 3cabazitaxel 3abiraterone 3Radiotherapy, Intensity-Modulated 3Radiosurgery 3Pioglitazone 3Paclitaxel 3Exercise 3Brachytherapy 3Blood Specimen Collection 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × Prostatic Neoplasms × Blood Specimen Collection × Clear all
NCT02869282 2025-09-17

CHEMOPROST

Institut Bergonié

Withdrawn
Genitourinary

Prostatic Neoplasms

NCT03987568 2022-12-21

Characterize Tumor Hypoxia by Magnetic Resonance Imaging

Wake Forest University Health Sciences

Phase NA Withdrawn
Genitourinary

Prostatic Neoplasms

NCT02742259 2019-03-26

VPCA-B+PIV

Celsee Diagnostics

Withdrawn
Genitourinary

Neoplastic Cells, Circulating, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡